Disease

Heart Failure

Review Report on Heart Failure Target / Biomarker Content of Review Report on Heart Failure Target / Biomarker
Heart Failure


About the Disease
Congestive Heart Failure, also known as congestive heart disease, is related to cardiomyopathy, dilated, 1e and orthostatic intolerance, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Congestive Heart Failure is CDKN2B-AS1 (CDKN2B Antisense RNA 1), and among its related pathways/superpathways are Cardiac conduction and "Antiarrhythmic Pathway, Pharmacodynamics". The drugs Salbutamol and Thalidomide have been mentioned in the context of this disorder. Affiliated tissues include Adipose and Lateral Plate Mesoderm, and related phenotypes are muscle and homeostasis/metabolism

Common Targets
G148 | G259249 | G5468 | G5978 | G7276 | Protein Kinase B (PKB/Akt) (nonspecified subtype) | G3738 | G1026 | cAMP Phosphodiesterase (nonspecified subtype) | G6548 | G1845 | G3782 | G5879 | G406921 | G10452 | G6261 | P36692 | G59272 | G2053 | G4128 | G2597 | G6530 | Alpha-2 Adrenergic receptors (nonspecified subtype) | G5293 | Carnitine O-Palmitoyltransferase 1 (CPT-1) (nonspecified subtype) | G5163 | G8514 | Phospholipase D (nonspecified subtype) | Folate Receptor (nonspecified subtype) | Interleukin-1 (nonspecified subtype) | G3958 | G1950 | G241 | G2908 | G5609 | G23476 | G2864 | G6093 | G142 | G2626 | G1432 | G3752 | G1586 | G183 | G9518 | Phosphodiesterase 1 (PDE1) (nonspecified subtype) | G4314 | G2784 | G10320 | G5578 | Lipoxygenase (nonspecified subtype) | G6559 | G1902 | G7852 | G2688 | G3065 | Serum/glucocorticoid regulated kinase (Sgk) (nonspecified subtype) | G59341 | Voltage-gated K(v) channel (nonspecified subtype) | G5350 | G9370 | G5739 | G5742 | G4217 | G90550 | G4524 | G7709 | G846 | Estrogen receptor (nonspecified subtype) | G2099 | G3156 | P12327 | G5291 | P11019 | Somatostatin receptor (nonspecified subtype) | G5290 | G9722 | Endothelin-Converting Enzymes (ECE) (nonspecified subtype) | P6320 | G759 | G553 | G5743 | G3357 | G6046 | G134 | G6352 | G43 | G4886 | G83461 | G5241 | G3105 | G3274 | G5243 | G6197 | G187 | G23411 | G283208 | G5535 | G3084 | P6463 | Acid-Sensing Ion Channel (ASIC) (nonspecified subtype) | Thyroid hormone receptor (nonspecified subtype) | G5479 | Matrix Metalloproteinase (MMP) (nonspecified subtype) | G79001 | G1020 | C-X-C Chemokine Receptor CXCR1/CXCR2 (IL-8 Receptor) (nonspecified subtype) | G52 | G51776 | G25776 | G283576 | G115209 | P40594 | G51393 | Chymotrypsin (nonspecified subtype) | G3360 | G5024 | G8913 | G5880 | IL-1 Receptor (nonspecified subtype) | G1859 | G1956 | G8841 | G11059 | G771 | G818 | G84649 | G8600 | G5533 | G3290 | G4318 | G6446 | P6884 | CDK9/Cyclin T1 | G3630 | Relaxin receptor (nonspecified subtype) | G6820 | G765 | G2357 | G995 | G1496 | G481 | G7421 | G5164 | G2938 | G54471 | G1621 | G7046 | G2147 | G5152 | G135 | G157 | G729230 | G122042 | G1374 | G6563 | G5481 | G112616 | G7136 | G1490 | Sodium channel (nonspecified subtype) | Transforming growth factor (nonspecified subtype) | G3758 | G1025 | G958 | G2159 | G26092 | G8856 | cGMP Phosphdiesterase (PDE) (nonspecified subtype) | G406990 | G2952 | G1244 | G3795 | G4914 | G4233 | G7498 | G255738 | G554 | G6550 | G4773 | G783 | G57572 | G5770 | G4846 | G7189 | Guanylate cyclase (nonspecified subtype) | G590 | G7137 | G5020 | G3248 | G64094 | G7097 | G100526835 | G2932 | G649 | G367 | G155 | Chloride channel (nonspecified subtype) | P10727 | G1910 | G2064 | G5595 | P10728 | P6278 | G4170 | G836 | Adenylate Cyclase (nonspecified subtype) | Histone acetyltransferase (HAT) (nonspecified subtype) | G406991 | G4987 | G51422 | G904 | G3553 | G4313 | G7433 | G51086 | G10267 | Protein Kinase D (PKD) (nonspecified subtype) | G1511 | G2837 | Mitogen-Activated Protein Kinase (nonspecified subtype) | G766 | G2696 | G56947 | G3569 | G1903 | G1482 | G2646 | G407014 | G59350 | G140 | G23452 | Neurotrophic Tyrosine Kinase Receptor (TRK) (nonspecified subtype) | Integrin alphaIIbbeta3 (fibrinogen gpIIb/IIIa) receptor | G5340 | G5734 | G377677 | G3356 | G8654 | G6262 | G4193 | G54578 | G3753 | G9620 | Na+/K+-ATPase (nonspecified subtype) | G4878 | G873 | G3748 | G7422 | K(ATP) Channel (nonspecified subtype) | G3741 | G7225 | G5601 | P16964 | G153 | G719 | G2264 | G4311 | G1812 | G111 | G5327 | G5476 | G815 | G100379251 | G3169 | G6833 | G7140 | G3558 | G2166 | Vascular endothelial growth factor receptor (VEGFR) (nonspecified subtype) | G54106 | G8829 | G3062 | beta-Adrenoceptor (nonspecified subtype) | Trypsin (nonspecified subtype) | G5034 | G2538 | G10060 | Elastase (nonspecified subtype) | G10631 | G10203 | G4843 | G3458 | G7341 | G9927 | G6750 | G4879 | G145957 | G185 | G2950 | G610 | G3269 | G7434 | Pyruvate dehydrogenase kinase (nonspecified subtype) | G3717 | Caspase (nonspecified subtype) | G4322 | G823 | P11025 | Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) (nonspecified subtype) | G9498 | G58472 | Transforming growth factor beta (nonspecified subtype) | G8288 | G57007 | G80128 | G84676 | G10072 | G9475 | P6058 | G154 | G5138 | L-Type calcium channel (nonspecified subtype) | G50508 | Dopamine receptor (nonspecified subtype) | G5147 | G5579 | P18298 | G6256 | G5140 | G10803 | G6323 | G6869 | G7124 | G7428 | G3579 | G1230 | G3784 | G2066 | G760 | G2944 | G2358 | G10008 | G125170 | G5289 | G1234 | 5-Hydroxytryptamine Receptor 2 (5-HT2) (nonspecified subtype) | G8019 | G57104 | alpha1-Adrenoceptor (nonspecified subtype) | P2X Receptor (nonspecified subtype) | Histone deacetylase (nonspecified subtype) | G5444 | Sterol O-acyltransferase (ACAT) (nonspecified subtype) | P13024 | P16740 | G1786 | G817 | P6321 | G28996 | G4047 | G133 | Poly [ADP-ribose] polymerase (nonspecified subtype) | G23704 | Vasopressin Receptor (nonspecified subtype) | G348 | G6523 | Gastric H+/K+-ATPase | G768 | G114548 | G51185 | G5167 | G10135 | G5532 | G123876 | G2028 | G8170 | G9379 | Actin (nonspecified subtype) | G7415 | G2869 | G993 | Adenosine receptor (nonspecified subtype) | G1588 | G7092 | G4160 | G5534 | G32 | P24924 | G1814 | G4088 | G3082 | G1499 | G186 | G5328 | G5602 | G2984 | Nitric oxide synthase (NOS) (nonspecified subtype) | G340061 | G23417 | G27113 | G84749 | G3818 | G4317 | G2625 | G9992 | G4363 | G4602 | G1889 | G23408 | G10295 | Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) (nonspecified subtype) | G7157 | G9365 | Hypoxia-Inducible Factor Prolyl Hydroxylase (nonspecified subtype) | G4881 | G2740 | G338 | Potassium Channels (nonspecified subtype) | G54583 | G7099 | G2146 | G3790 | G7040 | G2149 | G11103 | Myosin (nonspecified subtype) | G3764 | G5294 | G29974 | Angiotensin receptor (AT) (nonspecified subtype) | G673 | G1719 | G7093 | G5021 | G28959 | G56606 | G3756 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3 (PDE3) (nonspecified subtype) | G10082 | Voltage-Gated Calcium Channel alpha-2/delta (nonspecified subtype) | Endothelin receptor (nonspecified subtype) | G1585 | G10730 | NADPH Oxidase (nonspecified subtype) | G10257 | G6414 | Rho kinase (ROCK) (nonspecified subtype) | G1839 | G8737 | P10999 | G1901 | Fibroblast Growth Factor Receptor (FGFR) (nonspecified subtype) | G6331 | G983 | G4312 | G4323 | G3305 | G56729 | G1129 | G5318 | G4567 | G1594 | G4625 | G5972 | G31 | Calcium/calmodulin-dependent protein kinase type II (CaMK-II) | Dual Specificity Mitogen-Activated Protein Kinase Kinase (MEK) (nonspecified subtype) | G5266 | G59340 | G64840 | G2863 | Mitogen-activated protein kinase (JNK) (nonspecified subtype) | Mitogen-activated protein kinase p38 (MAPK p38) (nonspecified subtype) | P5859 | G4353 | G3956 | G156 | P17840 | G1395 | G10013 | G3091 | G9531 | P5759 | G1215 | G4882 | G6506 | G4803 | G3174 | G387 | G1909 | G1636 | G11318 | Phosphodiesterase (nonspecified subtype) | G6097 | Vasopressin V1 Receptor (nonspecified subtype) | G152 | G8648 | G8974 | G5139 | G105379030 | G3123 | G3363 | G6546 | G595 | Inward Rectifier Potassium Channel (nonspecified subtype) | G6495 | G2870 | G3066 | Ryanodine receptor (nonspecified subtype) | G11255 | Phosphodiesterase IV (PDE4) (nonspecified subtype) | G6916 | G1991 | Glutathione peroxidase (nonspecified subtype) | G9718 | G4194 | G552 | Na+/Ca2+ Exchanger (NCX) (nonspecified subtype) | G1269 | P16683 | G3557 | G4780 | G10451 | G6326 | G7222 | P5767 | Monoamine oxidase (MAO) (nonspecified subtype) | G3949 | G8493 | G5478 | G3106 | G4607 | G6524 | G151306 | Interleukin 17 (nonspecified subtype) | G3767 | G302 | G762 | G1017 | G120892 | Acetyl-CoA Carboxylases (ACC) (nonspecified subtype) | G8912 | G1813 | G5142 | G4306 | G2859 | G55867 | G3757 | G7508 | G2931 | Na+/H+ Exchanger (NHE) (nonspecified subtype) | G1557 | G5159 | G5599 | G8202 | G2475 | G5465 | G102 | P12956 | G22933 | G3131 | G1856 | G4883 | Phosphatidylinositol 3-kinase (PI3K) (nonspecified subtype) | G1759 | G79054 | G2693 | Calcium channel (nonspecified subtype) | P18508 | Protein kinase C (nonspecified subtype)

The "Target / Biomarker Review Report" is a comprehensive and customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about the Target(s) / Biomarker(s) of your choice related to Heart Failure, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

Other Diseases

Heart Septal Defects | Heavy Chain Disease | Heimler Syndrome | HELLP Syndrome | Hemangioblastoma | Hemangioendothelioma | Hemangioma | Hemimegalencephaly | Hemochromatosis | Hemochromatosis Type 1 | Hemochromatosis Type 2 | Hemoglobinopathies | Hemolytic Anemia | Hemolytic Uremic Syndrome | Hemolytic Uremic Syndrome, Atypical | Hemophagocytic Lymphohistiocytosis | Hemophilia | Hemorrhage | Hemorrhagic Disorders | Hemorrhoids | Hemosiderosis | Hennekam Lymphangiectasia-lymphedema Syndrome | Hepatic Adenomatosis | Hepatic Steatosis | Hepatic Veno-occlusive Disease | Hepatitis | Hepatitis A | Hepatitis B, Chronic | Hepatitis C, Chronic | Hepatitis D | Hepatitis E | Hepatitis, Alcoholic | Hepatitis, Autoimmune | Hepatitis, Chronic | Hepatoblastoma | Hepatopulmonary Syndrome | Hepatorenal Syndrome | Hereditary Coproporphyria | Hereditary Elliptocytosis | Hereditary Folate Malabsorption | Hereditary Hemorrhagic Telangiectasia | Hereditary Hemorrhagic Telangiectasia Type 2 | Hereditary Inclusion Body Myopathy | Hereditary Mixed Polyposis Syndrome | Hereditary Multiple Exostoses | Hereditary Neuropathy With Liability To Pressure Palsies | Hereditary Pyropoikilocytosis | Hereditary Sensory And Autonomic Neuropathy | Hereditary Sensory Neuropathy Type 1 | Hereditary Spastic Paraplegia | Hereditary Spherocytosis | Hereditary Xerocytosis | Hermansky-Pudlak Syndrome | Hernia, Inguinal | Heroin Dependence | Herpes Genitalis | Herpes Simplex Dermatitis | Heterotaxy | Heterotopic Ossification | HIBCH Deficiency | Hidradenitis | Hidradenitis Suppurativa | High Molecular Weight Kininogen Deficiency | Histiocytic Sarcoma | Histiocytosis | Histoplasmosis | Hodgkin Lymphoma | Holoprosencephaly | Holt-Oram Syndrome | Homocystinuria | Hoyeraal-Hreidarsson Syndrome | Huntington's Disease | Huntington's Disease-like 2 | HUPRA Syndrome | Hydrocephalus | Hydrocephalus, Normal Pressure | Hydrolethalus Syndrome | Hydronephrosis | Hydrops Fetalis | Hyper IgE Syndrome | Hyperacusis | Hyperammonemia | Hyperandrogenemia | Hyperbilirubinemia | Hyperbilirubinemia, Neonatal | Hypercalcemia | Hypercalciuria | Hypercholesterolemia | Hypercholesterolemia, Familial | Hyperekplexia | Hypereosinophilic Syndrome | Hyperferritinemia-cataract Syndrome | Hyperglycemia | Hyperhomocysteinemia | Hyperinsulinemia | Hyperinsulinemic Hypoglycemia | Hyperinsulinism-hyperammonemia Syndrome | Hyperkalemic Periodic Paralysis | Hyperkeratosis | Hyperlipidemia | Hyperlipidemia Type V | Hyperlipidemia, Familial Combined | Hypermethioninemia | Hypermetropia | Hyperostosis | Hyperoxaluria | Hyperparathyroidism | Hyperparathyroidism, Primary | Hyperparathyroidism, Secondary | Hyperparathyroidism-jaw Tumor Syndrome | Hyperphenylalaninemia | Hyperphosphatasia With Intellectual Disability Syndrome 4 | Hyperprolactinemia | Hypersensitivity | Hypersensitivity Pneumonitis | Hypersomnia | Hypertelorism | Hypertension | Hypertension, Essential | Hypertension, Portal | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hypertensive Nephropathy | Hypertensive Retinopathy | Hyperthermia, Malignant | Hyperthyroidism | Hypertriglyceridemia | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive 1 | Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive 2 | Hypertrophy | Hyperuricemia | Hyperuricemic Nephropathy, Familial Juvenile | Hypervalinemia | Hypoalbuminemia | Hypobetalipoproteinemias | Hypocalcemia | Hypodontia | Hypogammaglobulinemia | Hypoglycemia | Hypogonadism | Hypohidrotic Ectodermal Dysplasia | Hypohidrotic Ectodermal Dysplasia, X-linked | Hypokalemia | Hypokalemic Periodic Paralysis | Hypolipoproteinemia | Hypomyelination With Atrophy Of Basal Ganglia And Cerebellum | Hypoparathyroidism | Hypophosphatasia | Hypophosphatemic Rickets With Hypercalciuria, Hereditary | Hypophosphatemic Rickets, Autosomal Recessive, 1 | Hypopigmentation | Hypopituitarism | Hypoplastic Left Heart Syndrome | Hypoproteinemia, Hypercatabolic | Hypospadias | Hypotension, Orthostatic | Hypothalamic Obesity | Hypothyroidism | Hypotonia-cystinuria Syndrome | Hypotrichosis | Hypotrichosis Simplex | Hypotrichosis, Congenital, With Juvenile Macular Dystrophy | ICF Syndrome | Ichthyosis | Ichthyosis Bullosa Of Siemens | Ichthyosis Hystrix, Curth-Macklin Type | Ichthyosis, X-linked | Idiopathic Multicentric Castleman Disease | Idiopathic Pulmonary Fibrosis | IgA Deficiency | IgA Nephropathy | Ileitis | IMAGe Syndrome | Imerslund-Grasbeck Syndrome | Immunoproliferative Disorders | Impetigo | Impulse Control Disorder | Inborn Errors Of Metabolism | Incontinentia Pigmenti | Infantile Liver Failure Syndrome 1 | Infantile Nephropathic Cystinosis | Infantile Neuroaxonal Dystrophy | Infantile Refsum Disease | Infantile Spasm | Infectious Diarrhea | Infertility | Infertility, Male | Inflammatory Bowel Disease | Inflammatory Joint Disease | Inflammatory Linear Verrucous Epidermal Nevus | Inflammatory Myofibroblastic Tumor | Inflammatory Myopathy | Influenza | Insulin Resistance | Insulinoma | Intellectual Disability, Autosomal Dominant 5 | Intermittent Claudication | Intermittent Explosive Disorder | Interstitial Lung Diseases | Intestinal Hypomagnesemia 1 | Intestinal Obstruction | Intestinal Pseudo-obstruction | Intestinal Tuberculosis | Intracerebral Hemorrhage | Intracranial Hypertension | Iron Deficiency Anemia | Iron Metabolism Disorders | Iron Overload | Irritable Bowel Syndrome | Ischemia | Isobutyryl-CoA Dehydrogenase Deficiency | Isovaleric Acidemia | Jacobsen Syndrome | Jalili Syndrome | Japanese Encephalitis | Jaundice, Obstructive | Jawad Syndrome | Johanson-Blizzard Syndrome | Joubert Syndrome | Joubert Syndrome 2 | Juvenile Hyaline Fibromatosis | Juvenile Myelomonocytic Leukemia | Juvenile Myoclonic Epilepsy | Juvenile Polyposis | Juvenile Xanthogranuloma | Kabuki Syndrome | Kabuki Syndrome 2 | Kallmann Syndrome | Kaposi Sarcoma | Kaposiform Hemangioendothelioma | Kashin-Beck Disease | Kawasaki Disease | KBG Syndrome | Kearns-Sayre Syndrome | Keloid | Keratitis | Keratitis-ichthyosis-deafness Syndrome | Keratoacanthoma | Keratoconjunctivitis | Keratoconus | Keratocystic Odontogenic Tumor | Keratopathy | Keratosis | Keratosis, Actinic | Keratosis, Seborrheic | Kernicterus | Kidney Stones | Kindler Syndrome | Kleine-Levin Syndrome | Klinefelter Syndrome | Klippel-Feil Syndrome | Knobloch Syndrome | Kohlschutter-Tonz Syndrome | Krabbe Disease | L-2-Hydroxyglutaric Aciduria | Lactose Intolerance | Lafora Disease | Lamellar Ichthyosis | Language Disorders | Large Granular Lymphocytic Leukemia | Larsen Syndrome | Lassa Fever | Lateral Meningocele Syndrome | Lathosterolosis | Lattice Corneal Dystrophy | Lattice Corneal Dystrophy Type 1 | Learning Disability | Leber Congenital Amaurosis | Leber Hereditary Optic Neuropathy | Left Ventricular Noncompaction | Leigh Syndrome | Leiomyoma | Leiomyosarcoma | Leishmaniasis, Cutaneous | Leishmaniasis, Visceral | Lennox-Gastaut Syndrome | Lentigo | LEOPARD Syndrome | Leprosy | Leri Pleonosteosis | Leri-Weill Dyschondrosteosis | Lesch-Nyhan Syndrome | Leukemia | Leukemia-lymphoma, Adult T-cell | Leukocyte Adhesion Deficiency | Leukocyte Adhesion Deficiency Type 1 | Leukodystrophies | Leukoencephalopathy, Progressive Multifocal | Leukoplakia | Leukoplakia, Oral | Lewy Body Dementia | Li-Fraumeni Syndrome | Lichen Planus | Lichen Sclerosus | Liddle Syndrome | Liebenberg Syndrome | Light Chain Amyloidosis | Ligneous Conjunctivitis | Limb Girdle Muscular Dystrophy | Lipid Metabolism Disorders | Lipid Storage Diseases | Lipid Storage Myopathy | Lipodystrophy | Lipoma | Lissencephaly 2 | Liver Diseases | Liver Failure | Liver Failure, Acute Infantile | LMNA-related Congenital Muscular Dystrophy | Localized Scleroderma | Loeys-Dietz Syndrome | Loeys-Dietz Syndrome Type 4 | Long QT Syndrome Type 1 | Long QT Syndrome Type 2 | Long QT Syndrome Type 3 | Long-chain 3-hydroxyacyl-coenzyme A Dehydrogenase Deficiency | Low Phospholipid Associated Cholelithiasis | Low Tension Glaucoma | LRBA Deficiency | Lung Diseases | Lupus Erythematosus | Lyme Disease | Lymphangioleiomyomatosis | Lymphangioma | Lymphangiomatosis | Lymphedema | Lymphedema-distichiasis Syndrome | Lymphoma | Lymphoma Lymphoblastic | Lymphoma, AIDS-related | Lymphoma, B-cell | Lymphoma, Follicular | Lymphoma, Mantle Cell | Lymphoma, Primary Cutaneous Anaplastic Large Cell | Lymphomatoid Granulomatosis | Lymphopenia | Lymphoproliferative Disease, X-linked | Lymphoproliferative Disorders | Lysosomal Acid Lipase Deficiency | Mabry Syndrome | Macrodactyly | Macrophage Activation Syndrome | Macrophagic Myofasciitis | Macular Corneal Dystrophy | Macular Corneal Dystrophy Type 1 | Macular Degeneration | Majeed Syndrome | Major Depression | Malaria | Malaria, Cerebral | Malignant Fibrous Histiocytoma | Malignant Peripheral Nerve Sheath Tumor | Malnutrition | Malonyl-CoA Decarboxylase Deficiency | Mandibuloacral Dysplasia With Type A Lipodystrophy | Mannosidase Deficiency Diseases | Maple Syrup Urine Disease | Marfan Syndrome | Marinesco-Sjogren Syndrome | Marshall-Smith Syndrome | Martsolf Syndrome | Mast Cell Leukemia | Mastitis | Maternally Inherited Diabetes And Deafness | McCune-Albright Syndrome | McKusick Type Metaphyseal Chondrodysplasia | McLeod Syndrome | Measles | Meckel-Gruber Syndrome | Meconium Ileus | Medium-chain Acyl-CoA Dehydrogenase Deficiency | Medulloblastoma | Meesmann Corneal Dystrophy | Megacystis-microcolon-intestinal Hypoperistalsis Syndrome | Megalencephaly | Megaloblastic Anemia | Meier-Gorlin Syndrome | Melanocytic Nevus | Melanoma | Melanoma, Malignant | Melanoma, Uveal | MELAS Syndrome | Meleda Disease | Melnick-Needles Syndrome | Membranous Nephropathy | Menetrier Disease | Meniere's Disease | Meningeal Melanocytoma | Meningioma | Meningioma, Benign | Meningitis | Meningococcal Infections | Meningococcal Meningitis | Menkes Disease | Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis | Mesothelioma, Malignant | Metabolic Diseases | Metabolic Syndrome | Metachondromatosis